Zobrazeno 1 - 10
of 95
pro vyhledávání: '"C Delvincourt"'
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 133:979-984
Resume Introduction La surveillance systematique par imagerie des malades atteints d’un melanome stade I n’etait pas recommandee en France dans la conference de consensus de 1994, mais est, en pratique, frequemment realisee. L’objectif de cette
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da50dac0a27e410329160068f1055a37
https://doi.org/10.1016/s0151-9638(06)71082-1
https://doi.org/10.1016/s0151-9638(06)71082-1
Autor:
Ph. Terrier, Serge Koscielny, J. Wafflart, C Delvincourt, A Daver, J. Goussard, J. C. Delarue, G. Ricolleau
Publikováno v:
European Journal of Cancer. 34:476-481
The purpose of this prospective multicentric study was to quantify the c-erbB-2 protein and investigate its relationship with DNA amplification and with various prognostic parameters of breast cancer. A total of 1062 primary operable human breast tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8f91964eca43f6ddeacba4c92f74d9
https://doi.org/10.1016/s0959-8049(97)10069-7
https://doi.org/10.1016/s0959-8049(97)10069-7
Autor:
J-P Marie, S Huet, A-M Faussat, J-Y Perrot, S Chevillard, V Barbu, C Bayle, J Boutonnat, F Calvo, L Campos-Guyotat, P Colosetti, J-L Cazin, P de Cremoux, C Delvincourt, C Demur, B Drenou, O Fenneteau, J Feuillard, A Garnier-Suillerot, P Genne, M-C Gorisse, P Gosselin, H Jouault, R Lacave, G Le Calvez, M-C Léglise, S Léonce, M Manfait, M Maynadié, H Merle-Béral, J-L Merlin, M Mousseau, H Morjani, F Picard, F Pinguet, P Poncelet, E Racadot, M Raphael, B Richard, J-F Rossi, N Schlegel, P Vielh, D-C Zhou, J Robert
Publikováno v:
Leukemia. 11:1086-1094
The wide discrepancies in the frequency of ‘positive’ samples for multidrug resistance (MDR) phenotype within the same type of tumor observed in the literature justified the need for the definition of consensus recommendations. To define standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b030b4fa5ab09931e842065f8e3a8c11
https://doi.org/10.1038/sj.leu.2400656
https://doi.org/10.1038/sj.leu.2400656
Autor:
Jacques Robert, C Maugard, Pierre Verrelle, Ph Genne, Jean-Pierre Marie, A Clary, M. Raphael, P. Colosetti, JL Merlin, J Charrier, F. Pinguet, L Danel-Moore, B. Richard, Sylvie Chevillard, M. Mousseau, F Calvo, C. Delvincourt, F Finat-Duclos, V Quillien, Pierre Validire, Anne-Marie Faussat, JC Kouyoumdjian, C Bayle, Ph Vielh, P Decrémoux, Lacave R, C Bonnal, Jean Bénard, J. Boutonnat, A Kataki, V. Barbu
Publikováno v:
Leukemia. 11:1095-1106
Since there is no consensus on the techniques for multidrug resistance (MDR) phenotype evaluation, many discrepancies concerning the importance and frequency of mdr1 gene expression in leukemias and solid tumors are observed in the literature. In ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7bc5cd14e9db3d44ff3d6f05debaf81
https://doi.org/10.1038/sj.leu.2400657
https://doi.org/10.1038/sj.leu.2400657
Autor:
Nancy Uhrhammer, V. Chabaud, C. Delvincourt, Dominique Stoppa-Lyonnet, Myriam Bronner, Sandrine M. Caputo, B. Jesson, Joanna Sokolowska, J. Fournier, Christine Toulas, Ivan Bièche, Violaine Bourdon, Laurent Castera, Danielle Muller, E. Barouk-Simonet, Rosette Lidereau, Françoise Bonnet, Y. J. Bignon, Agnès Hardouin, Valerie Vidal, Capucine Delnatte, Liliane Demange, Jean-Philippe Peyrat, Adrien Briaux, Catherine Noguès, Florence Coulet, Etienne Rouleau
Publikováno v:
Breast cancer research and treatment. 133(3)
Hereditary breast cancers account for up to 5-10 % of breast cancers and a majority are related to the BRCA1 and BRCA2 genes. However, many families with breast cancer predisposition do not carry any known mutations for BRCA1 and BRCA2 genes. We expl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a57dfefc21e86d1748d67ea8da987fc7
https://pubmed.ncbi.nlm.nih.gov/22476849
https://pubmed.ncbi.nlm.nih.gov/22476849
Autor:
J. Blin, F. Borson-Chazot, A. Carrie, Pascal Pigny, C. Delvincourt, Delphine Mirebeau-Prunier, Stéphane Pinson, Nathalie Bouzamondo, Marine Guillaud-Bataille, Véronique Barbu, Anne-Paule Gimenez-Roqueplo, J.M. Rey, V. Rohmer, S. Bezieau, S. Giraud, M. Lebeault, Anne Barlier
Publikováno v:
Annales d'Endocrinologie. 76:324
Les NEM2 sont des affections multiglandulaires liees a des mutations germinales dominantes du proto-oncogene RET. Nous reportons les resultats des tests realises par les laboratoires labellises par l’INCA (TEN-GEN) entre 2003 et 2013. Le but de cet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e821f468f522243956bdd473f9f2a94
https://doi.org/10.1016/j.ando.2015.07.931
https://doi.org/10.1016/j.ando.2015.07.931
[Diagnostic modalities of visceral metastases during follow-up of patients with stage I-II melanoma]
Publikováno v:
Annales de dermatologie et de venereologie. 133(12)
Although not recommended in France at the consensus conference of 1994, routine monitoring of patients with stage I melanoma using imaging techniques is commonly carried out. The aim of this retrospective regional study was to define methods for diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb899a8655c7eff4d49364912201a8a4
https://pubmed.ncbi.nlm.nih.gov/17185928
https://pubmed.ncbi.nlm.nih.gov/17185928
Publikováno v:
Annales de dermatologie et de venereologie. 128(8-9)
The exact incidence of skin cancers is not well established in France as in other european countries, except for cutaneous melanoma. It is the same for the part taken by dermatologists in the screening of skin malignancies. We have therefore planned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d9ed9ce31435d0fd9b47af0d1208573
https://pubmed.ncbi.nlm.nih.gov/11590338
https://pubmed.ncbi.nlm.nih.gov/11590338
Publikováno v:
Bulletin de l'Academie nationale de medecine. 182(3)
The occurrence of solid tumors spreading through the body is a major concern for the clinicians. Moreover, in numerous cases, metastases exhibit a multidrug resistant (MDR) pattern. This dual characteristic still remains supported by few biological e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3b8e4a67dbe06b9ee36029f3451ad16
https://pubmed.ncbi.nlm.nih.gov/9673058
https://pubmed.ncbi.nlm.nih.gov/9673058
Autor:
S, Chevillard, P, Vielh, P, Validire, J P, Marie, A M, Faussat, V, Barbu, C, Bayle, J, Bénard, C, Bonnal, J, Boutonnat, F, Calvo, J, Charrier, A, Clary, P, Colosetti, L, Danel-Moore, P, Decrémoux, C, Delvincourt, F, Finat-Duclos, P, Genne, A, Kataki, J C, Kouyoumdjian, R, Lacave, C, Maugard, J L, Merlin, J, Robert
Publikováno v:
Leukemia. 11(7)
Since there is no consensus on the techniques for multidrug resistance (MDR) phenotype evaluation, many discrepancies concerning the importance and frequency of mdr1 gene expression in leukemias and solid tumors are observed in the literature. In ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5382796ed72d80e837df60d32d669810
https://pubmed.ncbi.nlm.nih.gov/9204997
https://pubmed.ncbi.nlm.nih.gov/9204997